Market Research Logo

China Pharmaceuticals & Healthcare Q1 2019

China Pharmaceuticals & Healthcare Q1 2019

Key View:

The Chinese pharmaceutical market continues to hold significant potential as the largest in the Asia Pacific. The demandfor innovative treatments in China will be driven by the increasing burden of chronic diseases. New regulatory pathways andimprovements to China’s drug approval process will bolster long-term growth opportunities for drugmakers. However, ongoingchallenges with regards to medicine pricing and the impact of low levels of intellectual property protection will continue to poserisks to China's pharmaceutical market growth.

Key View
Industry Forecast
Pharmaceutical Market Forecast
Healthcare Market Forecast
Prescription Drug Market Forecast
Patented Drug Market Forecast
Generic Drug Market Forecast
OTC Medicine Market Forecast
Pharmaceutical Trade Forecast
Industry Risk/Reward Index
Asia Pacific Innovative Pharmaceuticals Risk/Reward Index
Innovative Pharmaceuticals Risk/Reward Index
Regulatory Development
Regulatory Review
13th Five-Year Plan: Key Points
Market Overview
China Pharmaceuticals & Healthcare Market Overview
Competitive Landscape
Company Profile
Bayer HealthCare
China Shijiazhuang Pharmaceutical Group (CSPC)
Eli Lilly (Lilly China)
Merck KGaA
North China Pharmaceutical Corporation
Shanghai Pharmaceuticals Holding Co
China Demographic Outlook
Pharmaceuticals & Healthcare Glossary
Pharmaceuticals & Healthcare Methodology

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report